Concepedia

JA Wagner

JW

Statistics

Publications

22

Citations

2K

H-Index

19

Active since

1986

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Merck Canada Inc. (Canada)

HealthInsight

Johns Hopkins University

JA Wagner is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, clinical pharmacology, and pharmacokinetics.

Publications per year

1986–2015

22

Publications

22

Brain voltage-sensitive calcium channel subtypes differentiated by omega-conotoxin fraction GVIA.

Ian J. Reynolds, JA Wagner, Solomon H. Snyder et al. · Proceedings of the National Academy of Sciences · 1986 · 302 citations

, , +17

Biomarkers and Surrogate End Points for Fit-for-Purpose Development and Regulatory Evaluation of New Drugs

JA Wagner, Subbu Williams, Chris Webster · Clinical Pharmacology & Therapeutics · 2006 · 201 citations

, , +14

Safety, Tolerability, and Pharmacokinetics of Raltegravir After Single and Multiple Doses in Healthy Subjects

Marian Iwamoto, LA Wenning, AS Petry et al. · Clinical Pharmacology & Therapeutics · 2007 · 170 citations

, , +17

Rifampin's Acute Inhibitory and Chronic Inductive Drug Interactions: Experimental and Model-Based Approaches to Drug–Drug Interaction Trial Design

Marc L. Reitman, Xiaoyan Chu, Xiaoxin Cai et al. · Clinical Pharmacology & Therapeutics · 2010 · 157 citations

, , +17

Effect of the Cathepsin K Inhibitor Odanacatib on Bone Resorption Biomarkers in Healthy Postmenopausal Women: Two Double-Blind, Randomized, Placebo-Controlled Phase I Studies

S. Aubrey Stoch, Stefan Zajic, Julie A. Stone et al. · Clinical Pharmacology & Therapeutics · 2009 · 156 citations

, , +17

1–5 of 22